ACEi and ARBS in Hypertension and Heart Failure

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book ACEi and ARBS in Hypertension and Heart Failure by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319097886
Publisher: Springer International Publishing Publication: October 16, 2014
Imprint: Springer Language: English
Author:
ISBN: 9783319097886
Publisher: Springer International Publishing
Publication: October 16, 2014
Imprint: Springer
Language: English

The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception. It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception. It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.

More books from Springer International Publishing

Cover of the book Clinical Cardiogenetics by
Cover of the book The NeuroMuscular System: From Earth to Space Life Science by
Cover of the book Data Analytics for Traditional Chinese Medicine Research by
Cover of the book Optical Wireless Communications by
Cover of the book Trauma and Migration by
Cover of the book Design of Reconfigurable Logic Controllers by
Cover of the book Heterogeneous Vehicular Networks by
Cover of the book Smart Grid Inspired Future Technologies by
Cover of the book The Future of Digital Business Innovation by
Cover of the book Verifiable Composition of Signature and Encryption by
Cover of the book Using Transparency Against Corruption in Public Procurement by
Cover of the book Spin-Orbit-Induced Spin Textures of Unoccupied Surface States on Tl/Si(111) by
Cover of the book The Bad Faith in the Free Market by
Cover of the book New Perspectives and Applications of Modern Control Theory by
Cover of the book Plasticity-Damage Couplings: From Single Crystal to Polycrystalline Materials by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy